Integration of new technologies into healthcare system requires precise and comprehensive study of a country’s legislation, funding system, and established treatment guidelines. We offer detailed assessment of existing healthcare interventions (such as health screening, innovative technologies or medicines, telemedicine, new medical devices, and others) on each level, from regional to national, and from different perspectives (patients, providers, society, etc.). It helps us develop strategies to improve the existing practices. Our research involves cost-effectiveness, cost-utility, cost-benefit, and budget impact analysis.
Building a comprehensive and accurate model is a key step in health economics, as it allows to create a full picture guiding healthcare decisions. Health economic modeling makes it possible to extrapolate costs and effectiveness beyond trial data, to reflect appropriate evidence and resource allocation, and to make head-to-head comparison of treatment protocols. Depending on the primary task (intervention, level or perspective demands), we use a variety of approaches to build a model. Usually, these are deterministic and stochastic models (Markov process, Monte Carlo simulations, etc.), probability theory algorithms and others.
Outcomes research is defined by ISPOR as “a scientific discipline which evaluates the effect of healthcare interventions on patient-related clinical, humanistic and economic outcomes".
We are ready to study all of these factors: clinical (efficacy, effectiveness, safety), humanistic (functionality, compliance, satisfaction, willingness-to-pay) and economic (costs, budgeting, financial burden, etc.). They can be analyzed individually or as composite measures to demonstrate product value to varying target audiences and be a part of health technology assessment.